Head-to-head · WeighScore
TelePeptide vs Trinity Meds
The verdict
TelePeptide takes it — 62.3/100 to 61.2/100, but only just.
TelePeptide grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TelePeptide is a LegitScript-certified US direct-pay telehealth practice offering physician-supervised compounded GLP-1 therapy — semaglutide and tirzepatide — in injectable and oral dissolvable tablet… Trinity Meds is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | TelePeptide | Trinity Meds |
|---|---|---|
| WeighScore | 62.3/100 | 61.2/100 |
| Grade | C | C |
| Scorecard rank | #273 | #300 |
| Semaglutide | $199/mo (starting dose, annual plan, compounded oral) | $149/mo (compounded) |
| Tirzepatide | $219/mo (starting dose, annual plan, compounded oral) | $199/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #273 · C
Strengths
- LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
- All-inclusive from $169/mo annual — physician eval + Rx + medication + shipping, no hidden fees
- Broadest formulation menu: injectable sema/tirz, oral dissolvable tablets, sema+naltrexone, microdose combos
- 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
- 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime
Where it loses points
- Compounded medications are not FDA-approved; no pharmacy partner named publicly
- Monthly billing costs more — $199/mo (monthly) vs $169/mo (annual) for semaglutide injectable; best rate requires annual prepay
- Labs not included in any plan
- Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
- Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average
Graded #300 · C
Strengths
- All-inclusive flat pricing — $149/month semaglutide, same price at every dose, no hidden fees
- Multi-month plans cut the cost further (semaglutide to $129/month, tirzepatide to $149/month)
- No insurance required, FSA eligible, with free shipping to your door
- Named operating entity (Trinity Meds Inc) and US-licensed clinicians via CareValidate Health
Where it loses points
- Doesn't publish the states it serves — you only learn eligibility after starting the assessment
- Pharmacy partners are described as 'multiple USA certified pharmacies' but none are named
- No terms-of-service page is posted (only a privacy policy)
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
- Military framing is marketing; the program and pricing are open to anyone who qualifies
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.